Skip to main content
. 2018 Nov 26;38(13):2305–2319. doi: 10.1038/s41388-018-0577-5

Fig. 2.

Fig. 2

Inhibition of miR-508-3p in ovarian cancer cells is sufficient to induce mesenchymal phenotype. a Gene set enrichment analysis confirmed EMT-related programs are upregulated in miR-508-3p low expression group in TCGA. b Inverse phase microscopy (upper panel) and E-cadherin and vimentin staining (lower panels) of OV56 cells transfected with miR-508-3p inhibitor or control miRNA (miR-Ctrl) for 72 h. Cell nuclei were stained with DAPI. c The protein levels of E-cadherin and vimentin in OV56 cells transfected with miR-508-3p inhibitor or control miRNA (miR-Ctrl) for 72 h. β-actin was used as a control. d The mRNA levels of EMT genes between OV56 cells transfected with miR-508-3p inhibitor or control miRNA (miR-Ctrl) for 72 h. β-actin was used as a control. e Transwell chamber analysis of OV56 cells transfected with miR-508-3p inhibitor or control miRNA (miR-Ctrl) for 72 h. f Wound healing analysis of OV56 cells transfected with miR-508-3p inhibitor or control miRNA (miR-Ctrl) for 72 h. In all bar plots, p-values are based on two-tailed Student’s t-tests (*P < 0.05, **P < 0.01)